- Home
- ARWR vs DOCN Comparison
ARWR vs DOCN Comparison
Compare ARWR & DOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | DOCN |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.5B |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARWR | DOCN |
|---|---|---|
| Price | $62.67 | $85.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $81.50 | $68.23 |
| AVG Volume (30 Days) | 2.0M | ★ 3.8M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 99.80 | ★ 183.15 |
| EPS | 0.22 | ★ 2.52 |
| Revenue | $16,142,321.00 | ★ $901,427,000.00 |
| Revenue This Year | N/A | $23.80 |
| Revenue Next Year | N/A | $30.02 |
| P/E Ratio | $284.77 | ★ $34.00 |
| Revenue Growth | N/A | ★ 15.48 |
| 52 Week Low | $10.66 | $25.45 |
| 52 Week High | $76.76 | $88.84 |
Technical Indicators
Market Signals| Indicator | ARWR | DOCN |
|---|---|---|
| Relative Strength Index (RSI) | 56.75 | 64.10 |
| Support Level | $60.60 | $50.35 |
| Resistance Level | $66.37 | $88.84 |
| Average True Range (ATR) | 3.10 | 6.41 |
| MACD | 0.62 | 0.31 |
| Stochastic Oscillator | 94.65 | 83.28 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.